CLEARPOINT CAPITAL

Clearpoint Capital is a financial services firm registered in the United States, with its registered address at 5 Copper Row, London, SE1 2LH, UK. The company was founded on 18 May 2022, making it a relatively new entrant in the financial sector. At present, public information about the firm’s specific operations is extremely limited, and no official website content or regulatory filings are independently verifiable.

Given the scarcity of publicly available data, traders should approach this entity with caution. The firm is not listed on any major regulatory register, and its risk score as assessed by industry databases stands at 49 out of 100, indicating a guarded level of risk. Without a transparent online presence or recognised authorisation, the broker’s exact product offerings and target clientele remain unclear.

Clearpoint Capital does not hold any known regulatory licences from reputable authorities such as the Financial Conduct Authority (FCA), the US Commodity Futures Trading Commission (CFTC), or the Cyprus Securities and Exchange Commission (CySEC). The absence of regulatory oversight is a significant red flag for traders who typically rely on licensed brokers for protection, including access to compensation schemes and dispute resolution mechanisms.

While the firm lists a London address, this does not imply UK regulation; many unregulated entities use such addresses to imply legitimacy. According to the FXCanary Scam Risk Score of 49 (Guarded), the broker poses a moderate level of risk, largely due to its lack of verifiable regulation and limited operational history.

Without an operational website or official documentation, it is not possible to confirm what financial products, if any, Clearpoint Capital offers. Typically, a firm styled as “capital” may engage in investment management, proprietary trading, or brokerage services, but no concrete evidence supports these assertions.

Traders seeking a retail forex or CFD broker will find no confirmed information on trading platforms, account types, or instrument ranges. In the absence of verifiable data, it is advisable to treat this entity as high-risk and avoid committing funds until further information emerges.

Given the lack of regulatory authorisation and transparent business profile, Clearpoint Capital is unlikely to suit retail traders who prioritise security and oversight. The firm may be intended for institutional or high-net-worth clients who do not rely on standard consumer protections, but even this is speculative.

For most traders, the guarded risk score and absence of a verifiable track record mean that alternative, regulated brokers should be considered. FXCanary strongly recommends only dealing with firms that hold valid licences from respected financial watchdogs.